Bartels GL - Search Results

1

Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.

Bartels GL, Remme WJ, den Hartog FR, Wielenga RP, Kruijssen DA. Bartels GL, et al. Cardiovasc Drugs Ther. 1995 Dec;9(6):749-53. doi: 10.1007/BF00879867. Cardiovasc Drugs Ther. 1995. PMID: 8850378 Clinical Trial.

2

Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.

Bartels GL, Remme WJ, Pillay M, Schönfeld DH, Cox PH, Kruijssen HA, Knufman NM. Bartels GL, et al. J Cardiovasc Pharmacol. 1992 Jul;20(1):157-64. J Cardiovasc Pharmacol. 1992. PMID: 1383625

3

Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure.

Bartels GL, Remme WJ, Wiesfeld AC, Kok FJ, Look MP, Krauss XH, Kruyssen HA. Bartels GL, et al. Cardiovasc Drugs Ther. 1990 Jun;4(3):705-12. doi: 10.1007/BF01856558. Cardiovasc Drugs Ther. 1990. PMID: 2076381 Clinical Trial.

4

Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.

Remme WJ, Kruijssen DA, van Hoogenhuyze DC, Krauss XH, Bartels GL, Storm CJ, de Leeuw PW. Remme WJ, et al. Among authors: bartels gl. J Cardiovasc Pharmacol. 1994 Nov;24(5):730-9. doi: 10.1097/00005344-199424050-00007. J Cardiovasc Pharmacol. 1994. PMID: 7532750 Clinical Trial.

5

Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.

Venneker EH, Remme WJ, van Hoogenhuyze DC, Krauss XH, Bartels GL, Kruijssen DA, Storm CJ, van Schelven D. Venneker EH, et al. Among authors: bartels gl. Cardiovasc Drugs Ther. 1994 Apr;8(2):211-9. doi: 10.1007/BF00877329. Cardiovasc Drugs Ther. 1994. PMID: 7918133 Clinical Trial.

6

Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.

Bartels GL, Remme WJ, Pillay M, Schönfeld DH, Kruijssen DA. Bartels GL, et al. Am J Cardiol. 1994 Jul 15;74(2):125-30. doi: 10.1016/0002-9149(94)90084-1. Am J Cardiol. 1994. PMID: 8023775 Free article. Clinical Trial.

7

Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?

Bartels GL, Remme WJ, Holwerda KJ, Kruijssen DA. Bartels GL, et al. Eur Heart J. 1996 Mar;17(3):414-20. doi: 10.1093/oxfordjournals.eurheartj.a014874. Eur Heart J. 1996. PMID: 8737216 Clinical Trial.

8

Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.

Remme WJ, van der Ent M, Bartels GL, van Schelven D, van Hoogenhuyze DC, Krauss XH, Kruijssen HA, Storm CJ. Remme WJ, et al. Among authors: bartels gl. Cardiovasc Drugs Ther. 1996 May;10(2):137-44. doi: 10.1007/BF00823591. Cardiovasc Drugs Ther. 1996. PMID: 8842505 Clinical Trial.

9

Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.

Van Den Heuvel AF, van der Ent M, van Veldhuisen DJ, Kruijssen DA, Bartels GL, Remme WJ. Van Den Heuvel AF, et al. Among authors: bartels gl. J Cardiovasc Pharmacol. 1998 Apr;31(4):506-12. doi: 10.1097/00005344-199804000-00006. J Cardiovasc Pharmacol. 1998. PMID: 9554797

10

Renal hemodynamic effects in patients with moderate to severe heart failure during chronic treatment with trandolapril.

van der Ent M, Remme WJ, de Leeuw PW, Bartels GL. van der Ent M, et al. Among authors: bartels gl. Cardiovasc Drugs Ther. 1998 Sep;12(4):395-403. doi: 10.1023/a:1007729002821. Cardiovasc Drugs Ther. 1998. PMID: 9825186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters